Preclinical strategies to assess QT liability and torsadogenic potential of new drugs: The role of experimental models
- 1 October 2004
- journal article
- review article
- Published by Elsevier in Journal of Electrocardiology
- Vol. 37, 7-14
- https://doi.org/10.1016/j.jelectrocard.2004.08.003
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Drug-Induced Prolongation of the QT IntervalNew England Journal of Medicine, 2004
- Pause-dependent torsade de pointes following acute myocardial infarctionJournal of the American College of Cardiology, 2001
- Acquired Long QT Syndromes and the Risk of ProarrhythmiaJournal of Cardiovascular Electrophysiology, 2000
- Inherited Long QT Syndromes:Journal of Cardiovascular Electrophysiology, 1999
- The Inherited Long QT SyndromeCardiology in Review, 1999
- Cisapride and Fatal ArrhythmiaNew England Journal of Medicine, 1996
- Terfenadine-associated ventricular arrhythmias and QTc interval prolongationAnnals of Epidemiology, 1995
- Risk of developing life-threatening ventricular arrhythmia associated with terfenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastineThe American Journal of Cardiology, 1994
- Quinidine-induced SyncopeBMJ, 1965
- Quinidine as a Cause of Sudden DeathCirculation, 1956